UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Subcutaneous Daratumumab (Dara) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients With Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival (OS) and Final Major Organ Deterioration Progression-Free Survival Results From the Phase 3 Andromeda

Carpinteiro, A; Kastritis, E; Palladini, GO; Minnema, MC; Wechalekar, AD; Jaccard, A; Lee, HC; ... Merlini, G; + view all (2025) Subcutaneous Daratumumab (Dara) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients With Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival (OS) and Final Major Organ Deterioration Progression-Free Survival Results From the Phase 3 Andromeda. Presented at: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, Cologne, Germany. Green open access

[thumbnail of Wechalekar_Subcutaneous Daratumumab (Dara) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients With Newly Diagnosed Light Chain (AL) Amyloidosis_Presentation.pptx] Slideshow
Wechalekar_Subcutaneous Daratumumab (Dara) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients With Newly Diagnosed Light Chain (AL) Amyloidosis_Presentation.pptx

Download (277kB)
Type: Conference item (Presentation)
Title: Subcutaneous Daratumumab (Dara) plus Bortezomib, Cyclophosphamide, and Dexamethasone (VCd) in Patients With Newly Diagnosed Light Chain (AL) Amyloidosis: Overall Survival (OS) and Final Major Organ Deterioration Progression-Free Survival Results From the Phase 3 Andromeda
Event: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie
Location: Cologne, Germany
Dates: 24th-27th October 2025
Open access status: An open access version is available from UCL Discovery
Publisher version: https://doi.org/10.1159/000548147
Language: English
Additional information: For the purpose of open access, the author(s) has applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising from this submission.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Medicine > Inflammation
URI: https://discovery.ucl.ac.uk/id/eprint/10219988
Downloads since deposit
1Download
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item